JP5296366B2 - Endurance improver for drugs and endurance drug - Google Patents
Endurance improver for drugs and endurance drug Download PDFInfo
- Publication number
- JP5296366B2 JP5296366B2 JP2007280078A JP2007280078A JP5296366B2 JP 5296366 B2 JP5296366 B2 JP 5296366B2 JP 2007280078 A JP2007280078 A JP 2007280078A JP 2007280078 A JP2007280078 A JP 2007280078A JP 5296366 B2 JP5296366 B2 JP 5296366B2
- Authority
- JP
- Japan
- Prior art keywords
- endurance
- fatty acid
- oil
- mass
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims description 16
- 229940079593 drug Drugs 0.000 title claims description 6
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 29
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 26
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 22
- 229930195729 fatty acid Natural products 0.000 claims description 22
- 239000000194 fatty acid Substances 0.000 claims description 22
- 239000003921 oil Substances 0.000 claims description 21
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 20
- 150000004665 fatty acids Chemical class 0.000 claims description 18
- 239000003925 fat Substances 0.000 claims description 17
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 13
- 229960002446 octanoic acid Drugs 0.000 claims description 13
- 230000006872 improvement Effects 0.000 claims description 11
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000000470 constituent Substances 0.000 claims description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 8
- 150000003626 triacylglycerols Chemical class 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 235000013305 food Nutrition 0.000 description 38
- 235000019198 oils Nutrition 0.000 description 20
- 235000019197 fats Nutrition 0.000 description 16
- -1 medium-chain fatty acid triglycerides Chemical class 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000002156 mixing Methods 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000386 athletic effect Effects 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 235000019484 Rapeseed oil Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000008157 edible vegetable oil Substances 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013310 margarine Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 125000005457 triglyceride group Chemical group 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- CSTRPYAGFNTOEQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O CSTRPYAGFNTOEQ-MGMRMFRLSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940016409 methylsulfonylmethane Drugs 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000012459 muffins Nutrition 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000008171 pumpkin seed oil Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
Landscapes
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、医薬品用持久力向上剤および持久力向上用医薬品に関し、特に、中鎖脂肪酸を構成脂肪酸に含むトリグリセリドを有効成分として含有する医薬品用持久力向上剤および持久力向上用医薬品に関するものである。
The present invention relates to a pharmaceutical for improving endurance and Contact medicament for endurance improving agent, in particular, it relates to a pharmaceutical for enhancing endurance agent Contact and for enhancing endurance medicaments which comprise triglycerides containing medium-chain fatty acids in the constituent fatty acids as an active ingredient Is.
持久力は、一定の負荷に対して運動を維持できる能力として定義される。また、ヒトに備わる独立した運動能力であって、筋力(パワー)、瞬発力(スピード)、調整力(コーディネーション)、柔軟性(可動性)と並ぶ基本的な運動能力とされている。さらに、持久力はいくつかの分類がなされており、負荷が作用する状況(動的・静的)、筋群の多さ(全身・局所)や時間(短時間・長時間)、エネルギー供給(無酸素・有酸素)、パフォーマンスとして現れるもの(パワー・スピード)とその具体的内容は多岐に渡る。 Endurance is defined as the ability to maintain exercise for a certain load. Moreover, it is an independent athletic ability provided to humans, and is a basic athletic ability along with muscle strength (power), instantaneous power (speed), adjustment power (coordination), and flexibility (mobility). Furthermore, endurance is classified into several categories: the situation where the load acts (dynamic / static), the number of muscle groups (whole body / local), time (short time / long time), energy supply ( Anaerobic and aerobic), what appears as performance (power and speed) and its specific contents are diverse.
持久力の評価は、競技種目によって求められる能力が異なるため、いくつも考案され、実施されている。大別すると、エネルギー供給の指標を求めることによる評価と、パフォーマンスを測定する評価に分けられる。 A number of endurance assessments have been devised and implemented because of the different abilities required for each event. It can be broadly divided into evaluations by obtaining energy supply indicators and evaluations that measure performance.
エネルギー供給の指標としては、一般に、最大酸素摂取量や無酸素作業性閾値が挙げられる。最大酸素摂取量測定や無酸素作業性閾値の測定法としては、トレッドミルや自転車エルゴメータを用いた方法が一般に用いられており、漸増(無段階ないし多段階)負荷を行って、心拍数、呼気ガスや血中乳酸値を測定することにより実施される。 In general, examples of the energy supply index include a maximum oxygen intake amount and an anaerobic workability threshold. A method using a treadmill or a bicycle ergometer is generally used as a method for measuring the maximum oxygen intake or anaerobic threshold, and gradually increasing (stepless or multistep) loading, heart rate, expiration It is carried out by measuring gas and blood lactic acid levels.
また、パフォーマンスを測定する評価としては、一定の負荷量を与えたときの継続時間や仕事量を与えたときの到達時間といった時間を指標とするものと、一定の時間を与えたときの発揮パワーやスピードといった他の運動能力を指標とするものがある。 In addition, as an evaluation to measure performance, there are indicators that use time such as duration when given load is given and arrival time when given work, and power that is given when given time And other athletic skills such as speed and speed.
持久力を向上することは、上記のように競技によってその内容は異なるものの、運動能力向上の一要素として、競技力を向上させる上でも重要である。 Improving endurance is important for improving competitiveness as an element of improving athletic ability, although the contents differ depending on the competition as described above.
持久力を向上させるためには、日常の身体トレーニングが重要な位置を占めるが、トレーニングの結果として得られる持久力の向上には毎日の生活における食事が重要であることも近年認められている。 In order to improve endurance, daily physical training occupies an important position, but it has recently been recognized that diet in daily life is important for improving endurance obtained as a result of training.
そこで、食事により持久力を向上させるための有効成分について種々の研究がなされている(例えば、特許文献1および特許文献2参照)。 Therefore, various studies have been made on active ingredients for improving endurance by eating (see, for example, Patent Document 1 and Patent Document 2).
一方、中鎖脂肪酸トリグリセリドは、酸化安定性が高く凝固点や粘度が低いこと、無色透明に近く溶解性が高いことから、食品用油溶性香料・色素の溶剤、食品用離形油・潤滑油あるいは医薬品原料などに利用されてきた。また、吸収性が良く、糖類に比べてエネルギー比率が高いことから、効率のよいエネルギー補給を目的として経腸栄養剤の原料としても利用されている。 On the other hand, medium-chain fatty acid triglycerides have high oxidative stability, low freezing point and viscosity, and are almost colorless and transparent, and have high solubility. It has been used for pharmaceutical raw materials. Moreover, since it has good absorbability and a higher energy ratio than saccharides, it is also used as a raw material for enteral nutrients for the purpose of efficient energy supplementation.
中鎖脂肪酸トリグリセリドを含有する食品組成物としては、例えば、特許文献3に、中鎖脂肪酸トリグリセリドと糖質とを含有する食品組成物が、肝臓及び筋中のグリコーゲンの貯蔵に寄与し得ること、および栄養補給、疲労回復、スタミナ増強等に有用であることが記載されている。 As a food composition containing a medium chain fatty acid triglyceride, for example, in Patent Document 3, a food composition containing a medium chain fatty acid triglyceride and a saccharide can contribute to storage of glycogen in the liver and muscle, It is described that it is useful for nutritional supplementation, fatigue recovery, stamina enhancement and the like.
しかしながら、持久力向上機能については、中鎖脂肪酸トリグリセリドを普段の食生活に無理なく取り入れて摂取することによって、持久力を向上させる機能を有することは明らかにされていない。
上述したように、食事により持久力を向上させるための有効成分が求められており、特に、簡便に摂取することができ、且つ、持久力を向上させることができるものであって、尚且つ、副作用の懸念がなく使用できる食品等が望まれている。 As described above, there is a need for an active ingredient for improving endurance by eating, and in particular, it can be easily consumed and can improve endurance, and Foods that can be used without concern for side effects are desired.
従って、本発明の目的は、簡便に摂取することができ、且つ、副作用の懸念がなく使用できる医薬品用持久力向上剤および持久力向上用医薬品を提供することである。
Accordingly, an object of the present invention can be easily ingested, and is to provide a pharmaceutical for enhancing endurance agent Contact and enhancing endurance drugs that can be used without side effects concerns.
本発明者らは、上記課題を解決するために鋭意研究を重ねた結果、中鎖脂肪酸を構成脂肪酸に含むトリグリセリド(以下、中鎖脂肪酸トリグリセリドという。)が優れた持久力向上効果を有すること、および日常生活において簡便に摂取が可能であることから、持久力向上用の食品や医薬品として有用であることを見出し、本発明を完成するに至った。 As a result of intensive studies to solve the above-mentioned problems, the present inventors have an excellent endurance-improving effect of triglycerides containing medium-chain fatty acids in constituent fatty acids (hereinafter referred to as medium-chain fatty acid triglycerides). And since it can be ingested easily in daily life, it has been found useful as a food or a drug for improving endurance, and the present invention has been completed.
本発明は、上記目的を達成するために、中鎖脂肪酸トリグリセリドを有効成分として5質量%以上含有し、前記中鎖脂肪酸トリグリセリドの構成脂肪酸の95質量%以上が炭素数8および10の飽和脂肪酸(カプリル酸およびカプリン酸)であり、その質量比率がカプリル酸/カプリン酸=70/30〜80/20であり、且つ、トリグリセリドの1,3位に結合した全脂肪酸中のカプリル酸の割合が65〜80質量%である医薬品用持久力向上剤を提供する。
In order to achieve the above object, the present invention contains a medium-chain fatty acid triglyceride as an active ingredient in an amount of 5% by mass or more, and 95% by mass or more of the constituent fatty acids in the medium-chain fatty acid triglyceride is a saturated fatty acid having 8 and 10 carbon atoms ( Caprylic acid and capric acid), the mass ratio is caprylic acid / capric acid = 70/30 to 80/20, and the proportion of caprylic acid in the total fatty acids bonded to the 1,3-positions of triglycerides is 65 Provided is a pharmaceutical endurance improver that is ˜80 mass%.
また、本発明は、上記目的を達成するために、上記本発明の医薬品用持久力向上剤を含有することを特徴とする持久力向上用医薬品を提供する。
Moreover, this invention provides the pharmaceutical for endurance improvement characterized by including the endurance improving agent for pharmaceuticals of the said invention in order to achieve the said objective.
なお、本発明で言う持久力向上作用とは、その摂取(特に継続的摂取)により一定の負荷量を与えたときの運動継続時間が延長することや、運動のパフォーマンスが向上・改善することを指し、これは運動中に疲労しにくくなる作用(抗疲労作用)と言うこともでき、前述の特許文献3に記載されているような運動等による疲労を回復する作用とは異なる。 The endurance improving action referred to in the present invention means that the duration of exercise when a certain amount of load is given by its ingestion (particularly continuous ingestion) is extended, and that the performance of exercise is improved / improved. This can also be called an action (anti-fatigue action) that makes it difficult to get tired during exercise, and is different from the action that recovers fatigue caused by exercise or the like as described in Patent Document 3 described above.
本発明によると、簡便に摂取することができ、且つ、副作用の懸念がなく使用できる医薬品用持久力向上剤および持久力向上用医薬品を提供することができる。
According to the present invention, it can be easily ingested, and, it is possible to provide a pharmaceutical for the endurance enhancer you and for enhancing endurance drugs that can be used without the side effects of concern.
〔本発明の実施の形態に係る持久力向上剤〕
本発明の実施の形態に係る持久力向上剤は、中鎖脂肪酸トリグリセリドを有効成分として含有する。
[Endurance improver according to the embodiment of the present invention]
The endurance improver according to the embodiment of the present invention contains medium-chain fatty acid triglyceride as an active ingredient.
(中鎖脂肪酸トリグリセリドの構成)
本発明における中鎖脂肪酸トリグリセリドは、中鎖脂肪酸を構成脂肪酸に含むトリグリセリド、すなわち、トリアシルグリセロールのことである。
(Composition of medium chain fatty acid triglyceride)
The medium chain fatty acid triglyceride in the present invention is a triglyceride containing a medium chain fatty acid as a constituent fatty acid, that is, triacylglycerol.
ここで、中鎖脂肪酸としては、炭素数が6〜12の脂肪酸、特に飽和脂肪酸であるのが好ましい。中でも、炭素数が偶数の飽和脂肪酸であるカプロン酸、カプリル酸、カプリン酸、ラウリン酸がより好ましく、炭素数が8〜10の飽和脂肪酸であるカプリル酸およびカプリン酸が特に好ましい。 Here, the medium chain fatty acid is preferably a fatty acid having 6 to 12 carbon atoms, particularly a saturated fatty acid. Among these, caproic acid, caprylic acid, capric acid, and lauric acid, which are saturated fatty acids having an even number of carbon atoms, are more preferable, and caprylic acid and capric acid, which are saturated fatty acids having 8 to 10 carbon atoms, are particularly preferable.
中鎖脂肪酸トリグリセリドの構成脂肪酸の90質量%以上(より好ましくは95〜100質量%)が炭素数8および10の飽和脂肪酸(カプリル酸およびカプリン酸)であって、その質量比率がカプリル酸/カプリン酸=60/40〜85/15(より好ましくは70/30〜80/20)であり、且つ、トリグリセリドの1,3位に結合した全脂肪酸中のカプリル酸の割合が60〜85質量%(より好ましくは65〜80質量%)であることが好ましい。 90% by mass or more (more preferably 95 to 100% by mass) of the constituent fatty acids of the medium chain fatty acid triglyceride is a saturated fatty acid (caprylic acid and capric acid) having 8 and 10 carbon atoms, and the mass ratio thereof is caprylic acid / caprin. Acid = 60/40 to 85/15 (more preferably 70/30 to 80/20), and the proportion of caprylic acid in the total fatty acids bonded to the 1,3-positions of triglycerides is 60 to 85% by mass ( More preferably, it is preferably 65 to 80% by mass.
(中鎖脂肪酸トリグリセリドの製造方法)
このような中鎖脂肪酸トリグリセリドの製造方法は特に限定されないが、例えばパーム核油やヤシ油由来の中鎖脂肪酸とグリセリンを原料として、エステル結合反応を行うことにより得ることができる。
(Method for producing medium chain fatty acid triglyceride)
Although the manufacturing method of such a medium chain fatty acid triglyceride is not specifically limited, For example, it can obtain by performing an ester bond reaction by using as a raw material the medium chain fatty acid and glycerol derived from palm kernel oil or coconut oil.
エステル結合反応の条件も特に限定されないが、例えば無触媒かつ無溶剤にて、常圧もしくは減圧下で副生成する水を除去しながら反応して得ることができる。もちろん、酸やアルカリなどの触媒、酵素や溶剤を用いた反応によっても、このような中鎖脂肪酸トリグリセリドを得ることが可能である。 The conditions of the ester bond reaction are not particularly limited, but can be obtained by, for example, reacting with no catalyst and no solvent while removing water produced as a by-product under normal pressure or reduced pressure. Of course, such a medium-chain fatty acid triglyceride can also be obtained by a reaction using a catalyst such as acid or alkali, an enzyme or a solvent.
混合比率を工夫したトリカプリル酸グリセリドとカプリン酸を混合し、位置特異性を有するリパーゼ、例えば、名糖産業製「リパーゼPL」を用いることにより、構成脂肪酸の90質量%以上が炭素数8および10の飽和脂肪酸(カプリル酸およびカプリン酸)であって、その質量比率がカプリル酸/カプリン酸=60/40〜85/15であり、且つ、トリグリセリドの1,3位に結合した全脂肪酸中のカプリル酸の割合が60〜85質量%である中鎖脂肪酸トリグリセリドを得ることができる。 By mixing tricaprylic acid glyceride and capric acid with a special mixing ratio and using a lipase having positional specificity, for example, “Lipase PL” manufactured by Meisho Sangyo Co., Ltd., 90% by mass or more of the constituent fatty acids have 8 and 10 carbon atoms. Of saturated fatty acids (caprylic acid and capric acid), the mass ratio of which is caprylic acid / capric acid = 60/40 to 85/15, and capryl in all fatty acids bonded to the 1,3-positions of triglycerides A medium chain fatty acid triglyceride having an acid ratio of 60 to 85% by mass can be obtained.
また、遺伝子組み換え植物の油糧種子から中鎖脂肪酸トリグリセリド自体を得る、又は、遺伝子組み換え植物の油糧種子から得られた中鎖脂肪酸を原料にして、中鎖脂肪酸トリグリセリドを製造することも可能である。 It is also possible to obtain medium chain fatty acid triglycerides per se from oil seeds of genetically modified plants, or to produce medium chain fatty acid triglycerides using medium chain fatty acids obtained from oil seeds of genetically modified plants. is there.
(持久力向上剤の組成)
本発明の実施の形態に係る持久力向上剤は、有効成分としての上記中鎖脂肪酸トリグリセリドを5質量%以上(〜100質量%)含有するのが好ましい。30〜85質量%がより好ましく、48〜80質量%がさらに好ましい。
(Composition of endurance improver)
The endurance improver according to the embodiment of the present invention preferably contains 5% by mass (˜100% by mass) of the medium chain fatty acid triglyceride as an active ingredient. 30-85 mass% is more preferable, and 48-80 mass% is further more preferable.
本発明の実施の形態に係る持久力向上剤は、中鎖脂肪酸トリグリセリド以外の成分を含有することができる。 The endurance improver according to the embodiment of the present invention can contain components other than medium-chain fatty acid triglycerides.
このような成分としては、特に限定されないが、通常の食用油脂、例えば大豆油、菜種油、高オレイン酸菜種油、コーン油、ゴマ油、ゴマサラダ油、シソ油、亜麻仁油、落花生油、紅花油、高オレイン酸紅花油、ひまわり油、高オレイン酸ひまわり油、綿実油、ブドウ種子油、マカデミアナッツ油、ヘーゼルナッツ油、カボチャ種子油、クルミ油、椿油、茶実油、エゴマ油、ボラージ油、オリーブ油、米油、米糠油、小麦胚芽油、パーム油、パーム核油、ヤシ油、カカオ脂、牛脂、ラード、鶏脂、乳脂、魚油、アザラシ油、藻類油、品種改良によって低飽和化されたこれらの油脂およびこれらの混合油脂、水素添加油脂、分別油脂等があげられる。 Examples of such ingredients include, but are not limited to, normal edible oils and fats such as soybean oil, rapeseed oil, high oleic rapeseed oil, corn oil, sesame oil, sesame salad oil, perilla oil, linseed oil, peanut oil, safflower oil, high olein Safflower oil, sunflower oil, high oleic sunflower oil, cottonseed oil, grape seed oil, macadamia nut oil, hazelnut oil, pumpkin seed oil, walnut oil, camellia oil, tea seed oil, sesame oil, borage oil, olive oil, rice oil, rice bran Oil, wheat germ oil, palm oil, palm kernel oil, palm oil, cocoa butter, beef tallow, lard, chicken fat, milk fat, fish oil, seal oil, algae oil, these oils and fats that have been desaturated by breeding Examples thereof include mixed fats and oils, hydrogenated fats and oils, and fractionated fats and oils.
また、ビタミンA、ビタミンE、植物ステロール、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、アスコルビン酸脂肪酸エステル、有機酸モノグリセリド、リグナン、コエンザイムQ、アミノ酸、メチルサルフォニルメタン、グルコサミン、コンドロイチン、アスコルビン酸ステアレート、アスコルビン酸パルミテート、リン脂質、オリザノール、ジグリセリド等も添加することができる。 Also, vitamin A, vitamin E, plant sterol, polyglycerol fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, ascorbic acid fatty acid ester, organic acid monoglyceride, lignan, coenzyme Q, amino acid, methylsulfonylmethane, glucosamine, chondroitin Ascorbic acid stearate, ascorbyl palmitate, phospholipid, oryzanol, diglyceride and the like can also be added.
なお、ビタミンAとは、肉や魚などの動物性食品に多く含まれるレチノールと、体内でレチノールに変わり緑黄色野菜や果物などの植物性食品に多く含まれるプロビタミンA(α-カロテン、β-カロテン、クリプトキサンチンなど)の総称をいい、また、合成によりつくられたものでも良い。また、ビタミンEとは、植物および穀物類に多く含まれる複数種のトコフェロールおよびトコトリエノールの総称で、それぞれ、α、β、γ、δの4種に分類されるものをいい、また、合成によりつくられたものでも良い。 Vitamin A refers to retinol, which is abundant in animal foods such as meat and fish, and provitamin A (α-carotene, β-, which is abundant in plant foods such as green-yellow vegetables and fruits that change to retinol in the body. Generic name of carotene, cryptoxanthin, etc.), and may also be synthesized. Vitamin E is a generic name for multiple types of tocopherols and tocotrienols that are abundant in plants and cereals, and is classified into four types of α, β, γ, and δ, respectively, and is synthesized by synthesis. It may be the one given.
これらのうち、食用油脂およびビタミンAから選ばれる1種以上を含有することが好ましい。食用油脂を含有する場合には、持久力向上剤全体の60質量%以下であるのが好ましく、より好ましくは、5〜55質量%、特に好ましくは、5〜50質量%である。また、ビタミンAを含有する場合には、持久力向上剤全体の0.00001〜0.01質量%であるのが好ましく、より好ましくは、0.00001〜0.003質量%である。 Among these, it is preferable to contain at least one selected from edible fats and vitamins A. When edible fats and oils are contained, it is preferably 60% by mass or less, more preferably 5 to 55% by mass, and particularly preferably 5 to 50% by mass with respect to the total endurance improver. Moreover, when it contains vitamin A, it is preferable that it is 0.00001-0.01 mass% of the whole endurance improving agent, More preferably, it is 0.00001-0.003 mass%.
上記食用油脂としては、例えば、上記食用油脂の2種以上を混合した食用油脂をエステル交換処理して得られるエステル交換食用油脂も用いることができる。エステル交換は、アルカリ触媒を用いたケミカル反応、酵素を用いた酵素反応があり、食用油脂の風味・色の点で酵素反応が好ましいが、これに限定するものではない。また、得られたエステル交換食用油脂の1,3位の脂肪酸と2位の脂肪酸の組成に偏りがあってもなくてもよい。 As said edible fats and oils, the transesterified edible fats and oils obtained by transesterifying the edible fats and oils which mixed 2 or more types of the said edible fats and oils can also be used, for example. The transesterification includes a chemical reaction using an alkali catalyst and an enzyme reaction using an enzyme, and the enzyme reaction is preferable in terms of flavor and color of edible fats and oils, but is not limited thereto. The composition of the fatty acid at the 1st and 3rd positions and the fatty acid at the 2nd position of the obtained transesterified edible oil may or may not be biased.
(持久力向上剤の形態)
本発明の実施の形態に係る持久力向上剤の形態は、特に限定されないが、カプセル、錠剤、パウダー剤などの経口投与製剤のあらゆる形態で使用可能である。
(Form of endurance improver)
Although the form of the endurance improving agent according to the embodiment of the present invention is not particularly limited, it can be used in all forms of oral administration preparations such as capsules, tablets, and powders.
(持久力向上剤の投与量)
本発明の実施の形態に係る持久力向上剤の投与量は、特に限定されるものではないが、大人1人あたり、有効成分としての中鎖脂肪酸トリグリセリドの量で6g/日以上、投与することが好ましい。
(Dose of endurance improver)
Although the dosage of the endurance improving agent according to the embodiment of the present invention is not particularly limited, it should be administered in an amount of 6 g / day or more in terms of the amount of medium-chain fatty acid triglyceride as an active ingredient per adult. Is preferred.
(持久力向上用食品および持久力向上用医薬品)
本発明の実施の形態に係る持久力向上剤は、食品(加工食品、調味料、菓子など)や医薬品などに添加してもよく、例えば、ゼラチンカプセル、食用油脂、ドレッシング、バター、マーガリン、調製マーガリン、ファットスプレッド、クリーム、アイスクリーム、マヨネーズ、ショートニング、ベーカリーミックス、パン、パイ、ケーキ、クッキー、ドーナツ、マフィン、スコーン、フライ食品、スナック菓子、チョコレート、トッピング、加工肉製品、冷凍食品、フライ食品、経腸栄養剤、静脈栄養剤、流動食に添加することができる。
(Food for improving endurance and pharmaceuticals for improving endurance)
The endurance improver according to the embodiment of the present invention may be added to foods (processed foods, seasonings, confectionery, etc.) and pharmaceuticals, for example, gelatin capsules, edible oils and fats, dressings, butters, margarines, preparations Margarine, fat spread, cream, ice cream, mayonnaise, shortening, bakery mix, bread, pie, cake, cookie, donut, muffin, scone, fried food, snack confectionery, chocolate, topping, processed meat products, frozen food, fried food, It can be added to enteral nutrients, parenteral nutrients, and liquid foods.
また、厚生労働省の許可を受けて、持久力向上や抗疲労に基づく機能(作用)に関する効果(用途)を表示した特定保健用食品として使用することも可能である。すなわち、中鎖脂肪酸トリグリセリドを持久力向上の有効成分として含有し、厚生労働省の許可に係る持久力向上に基づく機能(作用)に関する効果(用途)を効果(用途)として表示した持久力向上用食品(飲料を除く)を提供できる。 In addition, with the permission of the Ministry of Health, Labor and Welfare, it can be used as a food for specified health use that displays effects (uses) related to functions (actions) based on improving endurance and anti-fatigue. In other words, food for endurance improvement that contains medium chain fatty acid triglycerides as an active ingredient for improving endurance and displays the effect (use) related to the function (action) based on the endurance improvement according to the permission of the Ministry of Health, Labor and Welfare as the effect (use) (Excluding beverages).
上記持久力向上用食品中の水分を除く組成物中における中鎖脂肪酸トリグリセリドの含量は、3質量%以上であることが好ましく、5質量%以上であることがより好ましい。 The content of medium-chain fatty acid triglycerides in the composition excluding moisture in the food for improving endurance is preferably 3% by mass or more, and more preferably 5% by mass or more.
本発明の実施の形態に係る持久力向上剤、並びにこれを含有する持久力向上用食品および持久力向上用医薬品は、ヒトに限らず、ヒト以外の動物、例えば、ウマ、イヌ、ウシ、ニワトリのために用いることができる。 The endurance improving agent according to the embodiment of the present invention, and the endurance improving food and the endurance improving pharmaceutical containing the same are not limited to humans, but animals other than humans, such as horses, dogs, cows, chickens. Can be used for.
〔本発明の実施の形態の効果〕
本発明の実施の形態によれば、有効性が高く、安全で、なおかつ実施が容易な持久力向上剤、並びに、当該持久力向上剤を含有する食品および医薬品を提供することができる。これらの持久力向上剤、持久力向上用食品および医薬品を日常的に摂取することで、持久力が向上できるため、競技者、運動愛好家やレクリエーション実施者などの運動能力の向上が可能となり、又、これらの対象者の競技能力の向上効果が期待できる。
[Effect of the embodiment of the present invention]
According to the embodiment of the present invention, it is possible to provide an endurance improver that is highly effective, safe and easy to implement, and foods and pharmaceuticals containing the endurance enhancer. Endurance can be improved by taking these endurance improvers, endurance foods and pharmaceuticals on a daily basis, so it is possible to improve the athletic ability of athletes, exercise enthusiasts and recreational implementers, Moreover, the improvement effect of the competition ability of these subjects can be expected.
次に実施例により本発明を説明するが、本発明はこれらの実施例により限定されるものではない。なお、実施例2〜4は参考例である。
EXAMPLES Next, although an Example demonstrates this invention, this invention is not limited by these Examples. Examples 2 to 4 are reference examples.
日清オイリオグループ(株)製の中鎖脂肪酸トリグリセリド(商品名:O.D.O)を持久力向上剤1とした。 Medium chain fatty acid triglyceride (trade name: O.D.O) manufactured by Nisshin Oilio Group Co., Ltd. was used as endurance improver 1.
日清オイリオグループ(株)製の中鎖脂肪酸トリグリセリド(商品名:O.D.O)500gに、日清オイリオグループ(株)製の菜種油500gを混合し、持久力向上剤2を1kg得た。 500 g of rapeseed oil made by Nisshin Oilio Group was mixed with 500 g of medium chain fatty acid triglyceride (trade name: OD.O) made by Nisshin Oilio Group, and 1 kg of endurance improver 2 was obtained. .
日清オイリオグループ(株)製の中鎖脂肪酸トリグリセリド(商品名:O.D.O)900gに、雪印乳業(株)製のラードを100g混合し、持久力向上剤3を1kg得た。 100 g of lard made by Snow Brand Milk Products Co., Ltd. was mixed with 900 g of medium chain fatty acid triglyceride (trade name: OD.O) manufactured by Nisshin Oilio Group, and 1 kg of endurance improver 3 was obtained.
日清オイリオグループ(株)製の中鎖脂肪酸トリグリセリド(商品名:O.D.O)999gに、日清オイリオグループ(株)製のトコフェロール(商品名:トコフェロール85)を1g添加し、十分に攪拌・溶解し、持久力向上剤4を1kg得た。 Add 1 g of tocopherol (trade name: Tocopherol 85) made by Nisshin Oilio Group to 999 g of medium chain fatty acid triglyceride (trade name: OD) made by Nisshin Oilio Group Co., Ltd. After stirring and dissolving, 1 kg of endurance improver 4 was obtained.
日清オイリオグループ(株)製の中鎖脂肪酸トリグリセリド(商品名:O.D.O)750g、でんぷん・デキストリン混合物250g、水1500gを混合後、乳化機にて乳化し、スプレードライヤーにて水分が5%以下になるように噴霧乾燥し、持久力向上剤5を約1kg得た。 After mixing 750g of medium chain fatty acid triglyceride (trade name: O.D.O) made by Nisshin Oilio Group, 250g of starch / dextrin mixture and 1500g of water, the mixture was emulsified with an emulsifier. It was spray-dried to 5% or less, and about 1 kg of endurance improver 5 was obtained.
上記日清オイリオグループ(株)製の中鎖脂肪酸トリグリセリド(商品名:O.D.O)の構成脂肪酸のうち、99.9質量%が炭素数8および10の飽和脂肪酸であり、炭素数8および10の飽和脂肪酸の質量比率は、7.4:2.6であった。また、トリグリセリドの1,3位に結合した脂肪酸の組成において、炭素数8の飽和脂肪酸の割合は73質量%であった。なお、トリグリセリドの2位に結合した脂肪酸の割合は、Brockerhoff法(Brockerhoff, H., 「Stereospecific analysis of triglycerides: an alternative method.」, Journal of Lipid Research (U.S.A.), 1967年, 第8巻, 第3号, p.167−169)により求めた。 Among the constituent fatty acids of medium chain fatty acid triglyceride (trade name: OD.O) manufactured by Nisshin Oilio Group, 99.9% by mass is a saturated fatty acid having 8 and 10 carbon atoms, and 8 carbon atoms. The mass ratio of saturated fatty acids of 10 and 10 was 7.4: 2.6. Moreover, in the composition of the fatty acid bonded to the 1,3-position of the triglyceride, the ratio of the saturated fatty acid having 8 carbon atoms was 73% by mass. The ratio of fatty acid bonded to the 2-position of triglyceride is calculated according to the Brockerhoff method (Brockerhoff, H., “Stereospecific analysis of triglycerides: an alternative method.”, Journal of Lipid Research (USA), 1967, Vol. 8, Vol. 3, p.167-169).
実施例1の持久力向上剤1を用いて、ファットスプレッド(持久力向上用食品1)を以下の配合割合・調製方法で調製した。なお、このファットスプレッド(持久力向上用食品1)は、1食(14g)あたり持久力向上剤1を5g含有している。 Using the endurance improver 1 of Example 1, fat spread (food for endurance improvement 1) was prepared by the following blending ratio and preparation method. In addition, this fat spread (food 1 for endurance improvement) contains 5g of the endurance improver 1 per serving (14g).
〔配合割合(質量部)〕
食用精製加工油脂:30.8部
30%β−カロテン:10ppm
乳化剤:0.5部
水:27.2部
食塩:1.1部
粉乳:1部
香料:0.1部
持久力向上剤1:39.3部
[Mixing ratio (parts by mass)]
Edible refined processed oil: 30.8 parts 30% β-carotene: 10 ppm
Emulsifier: 0.5 part Water: 27.2 parts Salt: 1.1 parts Milk powder: 1 part Fragrance: 0.1 part Endurance improver 1: 39.3 parts
〔調製方法〕
食用精製加工油脂、30%β−カロテン、乳化剤、香料とともに持久力向上剤1を加熱混合し、その後、水、食塩、粉乳を加えて予備乳化後、コンビネーターにて急冷混練した。
[Preparation method]
The endurance improver 1 was heated and mixed together with edible refined processed oil and fat, 30% β-carotene, emulsifier, and fragrance, and then preliminarily emulsified with water, salt and powdered milk, and then rapidly kneaded and kneaded with a combinator.
実施例2のファットスプレッド(持久力向上用食品1)を用いて、栄養調整食品(持久力向上用食品2)を以下の配合割合・調製方法で調製した。なお、この持久力向上用食品2は、1食(100g)あたり持久力向上剤1を6g含有している。 Using the fat spread of Example 2 (endurance improving food 1), a nutritionally adjusted food (endurance improving food 2) was prepared by the following blending ratio and preparation method. The endurance improving food 2 contains 6 g of endurance improving agent 1 per meal (100 g).
〔配合割合(質量部)〕
小麦粉:33.3部
砂糖:29.9部
持久力向上用食品1:16.6部
加工でんぷん:8.3部
卵:3.3部
食物繊維:2.3部
脱脂粉乳:1.6部
栄養強化剤(ビタミンB1、B2、B6、ミネラル):1.2部
乳化剤:0.1部
香料:0.1部
水:3.3部
[Mixing ratio (parts by mass)]
Flour: 33.3 parts Sugar: 29.9 parts Endurance food: 16.6 parts Processed starch: 8.3 parts Egg: 3.3 parts Dietary fiber: 2.3 parts Nonfat dry milk: 1.6 parts Nutritional enhancer (vitamin B1, B2, B6, mineral): 1.2 parts Emulsifier: 0.1 part Fragrance: 0.1 part Water: 3.3 parts
〔調製方法〕
砂糖、持久力向上用食品1、卵、食物繊維、脱脂粉乳、栄養強化剤、乳化剤を混合し、さらに、小麦粉、加工でんぷん、香料を加えて混合した。その後、水を加えて練り、圧延・成型し、加熱・焼成した。
[Preparation method]
Sugar, food for improving endurance 1, egg, dietary fiber, skim milk powder, nutrient fortifier and emulsifier were mixed, and flour, processed starch and flavor were added and mixed. Then, water was added, kneaded, rolled and molded, heated and fired.
(持久力向上効果試験)
実施例3の持久力向上用食品2を用い、クロスオーバー法による持久力向上効果試験を実施した。対照食品として、持久力向上剤1を同量の汎用サラダ油(菜種油:大豆油=70:30(質量比)の調合油)に換えた以外は上記実施例2,3と同じ配合割合・調製方法により調製した栄養調整食品を用いた。
(Endurance improvement test)
The endurance improvement effect test by the crossover method was carried out using the endurance improvement food 2 of Example 3. As a control food, the same blending ratio and preparation method as in Examples 2 and 3 except that endurance improver 1 was replaced with the same amount of general-purpose salad oil (rapeseed oil: soybean oil = 70:30 (mass ratio) blended oil). The nutritionally adjusted food prepared by the above was used.
試験は週1回・30分以上の身体活動を3ヵ月以上継続して実施している健常成人8名(男性1名、女性7名)(クロスオーバー法)で行った。試験開始前に自転車エルゴメーターにて漸増負荷を与え各人の最大酸素摂取量を測定し、その際に得られた最大パワー(負荷)を求めた。試験前日までの13日間、継続して持久力向上用食品2又は対照食品を摂取させた。試験前日より12時間絶食の後、試験日の朝、持久力向上用食品2又は対照食品を摂取させた。 The test was conducted on 8 healthy adults (1 male, 7 females) (crossover method) who have been conducting physical activity once a week for 30 minutes or longer for 3 months or longer. Before the start of the test, a gradually increasing load was applied with a bicycle ergometer to measure the maximum oxygen intake of each person, and the maximum power (load) obtained at that time was determined. The endurance improving food 2 or the control food was continuously ingested for 13 days until the day before the test. After fasting for 12 hours from the day before the test, the endurance food 2 or the control food was ingested in the morning of the test.
摂食1時間後から、自転車エルゴメータに乗り、ウオームアップを5分間させた後、最大酸素摂取量の60%相当の負荷で40分間運動をさせ、引き続き最大酸素摂取量の80%相当の負荷で疲労困憊するまで運動を継続させ、最大酸素摂取量の80%相当の負荷で運動させたときの運動継続時間を測定した。この試験結果を図1に示す。 After 1 hour of eating, ride on a bicycle ergometer and let warm-up for 5 minutes, then exercise for 40 minutes with a load equivalent to 60% of the maximum oxygen intake, and then continue with a load equivalent to 80% of the maximum oxygen intake The exercise was continued until exhaustion, and the exercise duration was measured when exercised with a load equivalent to 80% of the maximum oxygen intake. The test results are shown in FIG.
さらに、ウオームアップ運動開始時、60%相当の負荷での運動開始15分後および30分後、並びに80%相当の負荷での運動開始直後に、採血及び自覚的運動強度(PRE;rating of perceived exertion,Borg指数)の測定を実施した。採血した血液から、携帯型血糖・乳酸測定器にて血糖値及び血中乳酸値を測定した。この試験結果を表1に示す。 Furthermore, at the start of warm-up exercise, blood sampling and subjective exercise intensity (PRE; rating of perceived) 15 minutes and 30 minutes after the start of exercise with a load equivalent to 60%, and immediately after the start of exercise with a load equivalent to 80%. Measurement of exertion, Borg index). From the collected blood, blood glucose level and blood lactic acid level were measured with a portable blood glucose / lactic acid measuring device. The test results are shown in Table 1.
図1に示したように、最大酸素摂取量の80%相当の負荷を与えた運動での運動継続時間は、本発明の持久力向上用食品2を摂取することにより、対照食品と比較して有意に延長された。図1に示した*印は、本発明の持久力向上剤を含有する持久力向上用食品2を摂取した際の平均値が、対照食品のそれと比較して統計学的に有意な差がある(危険率5%以下)ことを表す。 As shown in FIG. 1, the exercise duration in the exercise given a load equivalent to 80% of the maximum oxygen intake is compared with the control food by ingesting the endurance improving food 2 of the present invention. Significantly prolonged. The * mark shown in FIG. 1 shows a statistically significant difference in the average value when the endurance improving food 2 containing the endurance improving agent of the present invention is ingested compared to that of the control food. (Risk rate is 5% or less).
同様に、表1に示したように、運動中の血中乳酸値及び自覚的運動強度は、本発明の持久力向上用食品2を摂取することにより、運動中、運動20分後にその上昇が対照食品と比較して有意に抑制された。 Similarly, as shown in Table 1, the blood lactate level and the subjective exercise intensity during exercise are increased after 20 minutes of exercise during exercise by ingesting the endurance improving food 2 of the present invention. It was significantly suppressed compared with the control food.
これらのことから、本発明の持久力向上剤を含有する持久力向上用食品2は、継続摂取により持久力が有意に向上することが明らかとなった。 From these facts, it was revealed that the endurance improving food 2 containing the endurance improving agent of the present invention has significantly improved endurance by continuous intake.
Claims (4)
前記中鎖脂肪酸トリグリセリドの構成脂肪酸の95質量%以上が炭素数8および10の飽和脂肪酸(カプリル酸およびカプリン酸)であり、その質量比率がカプリル酸/カプリン酸=70/30〜80/20であり、且つ、トリグリセリドの1,3位に結合した全脂肪酸中のカプリル酸の割合が65〜80質量%である医薬品用持久力向上剤。 Containing 5% by mass or more of triglyceride containing medium chain fatty acid in constituent fatty acid (hereinafter referred to as medium chain fatty acid triglyceride) as an active ingredient,
95 mass% or more of the constituent fatty acids of the medium chain fatty acid triglyceride is a saturated fatty acid having 8 and 10 carbon atoms (caprylic acid and capric acid), and the mass ratio thereof is caprylic acid / capric acid = 70/30 to 80/20. The endurance improver for pharmaceuticals in which the ratio of caprylic acid in the total fatty acids bonded to positions 1 and 3 of triglycerides is 65 to 80% by mass.
A pharmaceutical for endurance improvement comprising the endurance improver for pharmaceuticals according to any one of claims 1 to 3 .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007280078A JP5296366B2 (en) | 2007-10-29 | 2007-10-29 | Endurance improver for drugs and endurance drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007280078A JP5296366B2 (en) | 2007-10-29 | 2007-10-29 | Endurance improver for drugs and endurance drug |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009107954A JP2009107954A (en) | 2009-05-21 |
JP5296366B2 true JP5296366B2 (en) | 2013-09-25 |
Family
ID=40776873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007280078A Active JP5296366B2 (en) | 2007-10-29 | 2007-10-29 | Endurance improver for drugs and endurance drug |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5296366B2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3019024B1 (en) * | 2013-06-28 | 2017-02-01 | Nestec S.A. | Compositions and methods for enhancing exercise performance |
JP5864685B2 (en) * | 2013-09-02 | 2016-02-17 | 日清オイリオグループ株式会社 | chocolate |
CN113181158A (en) * | 2013-11-14 | 2021-07-30 | 奥特吉尼克斯制药公司 | Solid composition of triglyceride and use thereof |
JP5864708B2 (en) * | 2013-11-15 | 2016-02-17 | 日清オイリオグループ株式会社 | Bakery confectionery dough and baked confectionery |
JP6075731B2 (en) * | 2013-12-17 | 2017-02-08 | 日清オイリオグループ株式会社 | Baked goods |
MX2017004662A (en) * | 2014-10-10 | 2017-07-26 | Nestec Sa | Compositions and methods for enhancing mobility or activity or treating frailty. |
JP6596185B2 (en) * | 2017-05-12 | 2019-10-23 | 日清オイリオグループ株式会社 | Total ketone body concentration increasing agent, oil and fat composition, pharmaceutical composition, food composition |
JP2021016375A (en) * | 2019-07-24 | 2021-02-15 | 日清オイリオグループ株式会社 | Aerobic motor function improver, food composition for aerobic motor function improvement, and pharmaceutical composition for aerobic motor function improvement |
JP7379451B2 (en) * | 2021-12-03 | 2023-11-14 | 株式会社天柳 | Gelato-like food containing protein and its manufacturing method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5747446A (en) * | 1980-09-05 | 1982-03-18 | Nippon Oil & Fats Co Ltd | Nutrious food composition |
JPH0829055B2 (en) * | 1986-09-12 | 1996-03-27 | 大塚製薬株式会社 | Food composition |
-
2007
- 2007-10-29 JP JP2007280078A patent/JP5296366B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2009107954A (en) | 2009-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5296366B2 (en) | Endurance improver for drugs and endurance drug | |
JP4116844B2 (en) | Oil composition | |
CN100421565C (en) | Oil/fat composition | |
CN1906280B (en) | A oil composition enriched in diglyceride with conjugated linoleic acid | |
JP4381037B2 (en) | Oil composition | |
JP4031219B2 (en) | Oil composition | |
CN101340819A (en) | Dietary supplements and prepared foods containing triglyceride-recrystallized non-esterified phytosterols | |
AU2002328058A1 (en) | Oil composition | |
JP4031218B2 (en) | Oil composition | |
JP2017070311A (en) | Nutritive composition | |
KR20110082052A (en) | Concentrated liquid diet | |
CN101810226A (en) | Fatty acid component balanced children type nutrition blended oil containing multiple active ingredients | |
JPWO2003074043A1 (en) | Body temperature raising agent | |
JP5547486B2 (en) | Composition containing sesamin and arachidonic acid | |
US20040142018A1 (en) | Regulator for amount of body fat | |
CN110139563A (en) | Vegetable lipid is promoted to excrete the external composition comprising psicose | |
JP5702292B2 (en) | Visceral fat loss inhibitor in Parkinson's disease patients | |
JP2004043337A (en) | Blood neutral fat concentration-adjusting agent | |
JP2006117557A (en) | Blood adiponectin level increasing agent | |
JP7356833B2 (en) | Peripheral thermostimulant | |
JP2019019069A (en) | Body fat reducing agent | |
JPWO2004022050A1 (en) | Lipid metabolism regulator and food and drink | |
JP2021016375A (en) | Aerobic motor function improver, food composition for aerobic motor function improvement, and pharmaceutical composition for aerobic motor function improvement | |
ES2221576B1 (en) | BLENDS OF OILS. | |
JPWO2003074042A1 (en) | Uncoupling protein expression enhancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101007 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121113 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121225 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130515 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130527 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130611 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130613 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5296366 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |